Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Grignani

Showing results (11-20 of 173) with videos related to

Pageof 18
Sort By:
La Clinica Terapeutica|March 15, 1974
[Antimetabolites in the therapy of human acute leukemia. Mechanism of action and factors conditioning the cellular response to the drugs. 3. Cellular kinetics and chemotherapy]F Grignani, M Martelli, M Tonato
Leukemia|April 1, 1994
Effect of the acute promyelocytic leukemia PML/RAR alpha protein on differentiation and survival of myeloid precursorsM Fagioli, F Grignani, P F Ferrucci, et al.
International Journal of Cancer|February 7, 1997
Genetics of APL and the molecular basis of retinoic acid treatmentT Casini, F Grignani, P G Pelicci
Oncogene|July 1, 1991
Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation propertiesP P Pandolfi, F Grignani, M Alcalay, et al.
Haematologica|May 1, 1988
Myelomonocytic-associated antigens in a case of genotypically, phenotypically and functionally B-cell lymphomaF Grignani, M Fizzotti, A M Liberati, et al.
Annals of Internal Medicine|October 1, 1985
Microangiopathic hemolytic anemia and pulmonary small-cell carcinomaS Davis, P Rambotti, F Grignani, et al.
Cancer|July 15, 1988
Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracilM Colozza, M Tonato, F Grignani, et al.
Molecular and Cellular Biology|August 1, 1997
Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signallingM Ruthardt, U Testa, C Nervi, et al.
Cell|July 10, 1992
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transductionG Pelicci, L Lanfrancone, F Grignani, et al.
Cell|August 13, 1993
The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cellsF Grignani, P F Ferrucci, U Testa, et al.
Pageof 18

Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
La Clinica Terapeutica|March 15, 1974
[Antimetabolites in the therapy of human acute leukemia. Mechanism of action and factors conditioning the cellular response to the drugs. 3. Cellular kinetics and chemotherapy]F Grignani, M Martelli, M Tonato
Leukemia|April 1, 1994
Effect of the acute promyelocytic leukemia PML/RAR alpha protein on differentiation and survival of myeloid precursorsM Fagioli, F Grignani, P F Ferrucci, et al.
International Journal of Cancer|February 7, 1997
Genetics of APL and the molecular basis of retinoic acid treatmentT Casini, F Grignani, P G Pelicci
Oncogene|July 1, 1991
Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation propertiesP P Pandolfi, F Grignani, M Alcalay, et al.
Haematologica|May 1, 1988
Myelomonocytic-associated antigens in a case of genotypically, phenotypically and functionally B-cell lymphomaF Grignani, M Fizzotti, A M Liberati, et al.
Annals of Internal Medicine|October 1, 1985
Microangiopathic hemolytic anemia and pulmonary small-cell carcinomaS Davis, P Rambotti, F Grignani, et al.
Cancer|July 15, 1988
Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracilM Colozza, M Tonato, F Grignani, et al.
Molecular and Cellular Biology|August 1, 1997
Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signallingM Ruthardt, U Testa, C Nervi, et al.
Cell|July 10, 1992
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transductionG Pelicci, L Lanfrancone, F Grignani, et al.
Cell|August 13, 1993
The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cellsF Grignani, P F Ferrucci, U Testa, et al.
Pageof 18